Mitsui Chemicals (4183) Q3 2025 earnings summary

Executive summary

• Operating income before special items for April–December 2024 rose 5% year-over-year to ¥75.8 billion, driven by strong Specialty Chemicals and Mobility Solutions, while Basic & Green Materials declined due to an ethylene plant failure.

• Sales revenue for April–December 2024 was ¥1,338.8 billion, up 5% or ¥64.3 billion year-over-year; net income attributable to owners was ¥37.7 billion, up 1% year-over-year.

• Segment reclassification was implemented following organizational reforms in April 2024.

Financial highlights

• Operating income before special items for FY2024 is forecast at ¥105.0 billion, up 9% year-over-year; net income expected at ¥56.0 billion.

• Dividend outlook is ¥150 per share, up ¥10 from the previous year; ¥10.0 billion in treasury stock was acquired.

• Free cash flow for April–December 2024 was ¥60.6 billion; full-year free cash flow is forecast at ¥15.0 billion.

• Net D/E ratio improved to 0.67–0.68; capital expenditure for FY2024 forecast at ¥168.0 billion.

Outlook and guidance

• Full-year sales revenue is projected at ¥1,825.0 billion, up ¥75.3 billion year-over-year, reflecting higher naphtha prices and exchange rates.

• Specialty Chemicals operating income before special items is expected to rise to ¥120.0 billion, mainly on higher sales volume.

• Life & Healthcare Solutions operating income before special items is forecast at ¥36.0 billion, up ¥6.0 billion; ICT Solutions at ¥29.0 billion, up ¥5.4 billion.

• Mobility Solutions operating income before special items is expected to decrease by ¥2.7 billion to ¥55.0 billion.

• Basic & Green Materials operating income before special items is forecast at ¥10.0 billion, up ¥1.6 billion.